These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cerebral gigantism with intermittent fractional hypopituitarism and normal sella turcica. Ludwig GD; Chaykin LB; Escueta AV Ann Intern Med; 1967 Jul; 67(1):123-31. PubMed ID: 6028644 [No Abstract] [Full Text] [Related]
4. Letter: Somatomedin in cerebral gigantism. Saenger P; Levine LS; Wiedemann E; Schwartz E; New MI J Pediatr; 1976 Jan; 88(1):155-6. PubMed ID: 1245925 [No Abstract] [Full Text] [Related]
5. [Cerebral gigantism. Apropos of a case with a study of somatotropin activity]. Stoll C; Luckel JC; Juif JG Pediatrie; 1971 Dec; 26(8):869-75. PubMed ID: 5138736 [No Abstract] [Full Text] [Related]
6. Gigantism and somatostatin neurons. Dalrymple AM J Neurosurg; 1995 Jun; 82(6):1100-1. PubMed ID: 7760191 [No Abstract] [Full Text] [Related]
8. The hypothalamus, brain-catecholamines, and drug therapy for gigantism and acromegaly. Sherman L; Kolodny HD Lancet; 1971 Apr; 1(7701):682-5. PubMed ID: 4101619 [No Abstract] [Full Text] [Related]
9. Growth hormone (GH) secretory dynamics in a case of acromegalic gigantism associated with hyperprolactinemia: nonpulsatile secretion of GH may induce elevated insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 levels. Yoshida T; Shimatsu A; Sakane N; Hizuka N; Horikawa R; Tanaka T J Clin Endocrinol Metab; 1996 Jan; 81(1):310-3. PubMed ID: 8550769 [TBL] [Abstract][Full Text] [Related]
10. [Gigantism with low serum level of growth hormone: a case report]. Ran X; Zhang L; Xiong P; Zhao T; Tong N; Li X Hua Xi Yi Ke Da Xue Xue Bao; 2001 Dec; 32(4):621-3. PubMed ID: 12528568 [TBL] [Abstract][Full Text] [Related]
11. [Growth hormone in health and disease]. Jelavić N Lijec Vjesn; 1971; 83(9):1079-83. PubMed ID: 5154075 [No Abstract] [Full Text] [Related]
12. Acromegalic gigantism with low serum level of growth hormone and elevated serum insulin-like growth factor-I. Miyazaki R; Yoshida T; Sakane N; Yasuda T; Umekawa T; Kondo M; Shimatsu A; Hizuka N; Sano T Intern Med; 1995 Mar; 34(3):183-7. PubMed ID: 7787324 [TBL] [Abstract][Full Text] [Related]
14. [Cerebral gigantism (apropos of a case with a study of somatotropic function)]. Gaudier B; Franchimont P; Ponté C; Nuyts JP; Ryckewaert P Pediatrie; 1969; 24(3):325-37. PubMed ID: 5795414 [No Abstract] [Full Text] [Related]
16. [Growth and growth hormone in "cerebral gigantism"]. Butenandt O; Knorr D Munch Med Wochenschr; 1973 Apr; 115(14):577-80. PubMed ID: 4740219 [No Abstract] [Full Text] [Related]
17. Gigantism produced in normal female rats by chronic treatment with pure pituitary growth hormone; growth and organ changes. SIMPSON ME; LI CH Anat Rec; 1947 Mar; 97(3):368. PubMed ID: 20341862 [No Abstract] [Full Text] [Related]
18. [Cerebral gigantism in children: determination of growth hormone in the plasma]. Sizonenko PC; Job JC; Sebouk S; Rossier A Arch Fr Pediatr; 1968 Feb; 25(2):151-61. PubMed ID: 5686253 [No Abstract] [Full Text] [Related]
19. Disappearance rate of endogenous and exogenous human growth hormone in man. Refetoff S; Sönksen PH J Clin Endocrinol Metab; 1970 Mar; 30(3):386-92. PubMed ID: 5412545 [No Abstract] [Full Text] [Related]
20. Gigantism produced in normal female rats by chronic treatment with pure pituitary growth hormone. EVANS HM; BECKS H Anat Rec; 1947 Mar; 97(3):333. PubMed ID: 20341824 [No Abstract] [Full Text] [Related] [Next] [New Search]